This landmark volume discusses the characteristics and impact of the remodeling
process on airway function and clinical disease expression within the airway in
asthma, covering pharmacological therapies and possible future targets relevant
to regulating the remodeling process.
Emphasizes the importance of treating underlying airway inflammation and the
relevance of structural alterations to the airway wall, including glandular
increases, enhanced collagen deposition within the submucosa, increased
vasculature, smooth hypertrophy, and hyperplasias
Tracing the development and maintenance of bronchial hyperresponsiveness,
decline in lung function, and loss of reversibility evident in chronic asthma,
Airway Remodeling
describes the contribution of inflammatory cells in the development of airway
structural changes
examines how pharmaceutical agents